BG103918A - Soluble sertraline compositions - Google Patents

Soluble sertraline compositions

Info

Publication number
BG103918A
BG103918A BG103918A BG10391899A BG103918A BG 103918 A BG103918 A BG 103918A BG 103918 A BG103918 A BG 103918A BG 10391899 A BG10391899 A BG 10391899A BG 103918 A BG103918 A BG 103918A
Authority
BG
Bulgaria
Prior art keywords
compositions
soluble
soluble sertraline
sertraline compositions
sertraline
Prior art date
Application number
BG103918A
Other languages
Bulgarian (bg)
English (en)
Inventor
Dwayne T. Friesen
Scott M. Herbig
Ravi M. Shanker
James B. West
Original Assignee
Pfizer Products Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=21971159&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=BG103918(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Pfizer Products Inc filed Critical Pfizer Products Inc
Publication of BG103918A publication Critical patent/BG103918A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0004—Osmotic delivery systems; Sustained release driven by osmosis, thermal energy or gas
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Neurosurgery (AREA)
  • Organic Chemistry (AREA)
  • Neurology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Inorganic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
BG103918A 1997-07-01 1999-11-23 Soluble sertraline compositions BG103918A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US5141397P 1997-07-01 1997-07-01
PCT/IB1998/000933 WO1999001120A1 (en) 1997-07-01 1998-06-15 Solubilized sertraline compositions

Publications (1)

Publication Number Publication Date
BG103918A true BG103918A (en) 2000-07-31

Family

ID=21971159

Family Applications (1)

Application Number Title Priority Date Filing Date
BG103918A BG103918A (en) 1997-07-01 1999-11-23 Soluble sertraline compositions

Country Status (34)

Country Link
EP (1) EP0999829A1 (ja)
JP (1) JP2000514100A (ja)
KR (1) KR100366373B1 (ja)
CN (1) CN1261794A (ja)
AP (1) AP1192A (ja)
AR (3) AR015917A1 (ja)
AU (1) AU742535B2 (ja)
BG (1) BG103918A (ja)
BR (1) BR9810739A (ja)
CA (1) CA2290974C (ja)
CO (1) CO4940495A1 (ja)
DZ (1) DZ2548A1 (ja)
EA (1) EA002481B1 (ja)
HN (1) HN1998000102A (ja)
HR (1) HRP980377A2 (ja)
HU (1) HUP0002236A3 (ja)
ID (1) ID23429A (ja)
IL (1) IL133076A (ja)
IS (1) IS5260A (ja)
MA (1) MA24587A1 (ja)
NO (1) NO996520L (ja)
OA (1) OA11243A (ja)
PA (1) PA8454301A1 (ja)
PE (1) PE97199A1 (ja)
PL (1) PL337804A1 (ja)
SK (1) SK181099A3 (ja)
TN (1) TNSN98124A1 (ja)
TR (1) TR199903297T2 (ja)
TW (1) TW550087B (ja)
UA (1) UA67741C2 (ja)
UY (1) UY25071A1 (ja)
WO (1) WO1999001120A1 (ja)
YU (1) YU68299A (ja)
ZA (1) ZA985708B (ja)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MXPA02006324A (es) 1999-12-23 2002-12-13 Pfizer Prod Inc Composiciones farmaceuticas que proporcionan concentraciones potenciadas de farmaco.
US20030086972A1 (en) * 2000-08-09 2003-05-08 Appel Leah E. Hydrogel-driven drug dosage form
EP1313473A2 (en) 2000-08-30 2003-05-28 Pfizer Products Inc. Sustained release formulations for growth hormone secretagogues
US20040191207A1 (en) * 2003-03-31 2004-09-30 Lipari John M. Alpha-hydroxy acid ester drug delivery compositions and methods of use
EP2117652B1 (en) * 2007-03-12 2013-09-25 DSM IP Assets B.V. Cosmetic compositions
KR20120116422A (ko) * 2009-12-29 2012-10-22 코와 가부시키가이샤 경구 투여용 의약 조성물
WO2011081117A1 (ja) * 2009-12-29 2011-07-07 興和株式会社 経口投与用固形医薬組成物
CN109908354A (zh) * 2017-12-12 2019-06-21 万特制药(海南)有限公司 盐酸舍曲林口服浓缩液及其制备工艺

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4803076A (en) * 1986-09-04 1989-02-07 Pfizer Inc. Controlled release device for an active substance
DK0415612T3 (da) * 1989-08-30 1993-12-13 Pfizer Anvendelse af sertralin til behandling af afhængigheder af kemiske stoffer
ZA97976B (en) * 1996-04-05 1997-08-18 Alza Corp Uniform drug delivery theraphy.

Also Published As

Publication number Publication date
AU742535B2 (en) 2002-01-03
IL133076A (en) 2003-12-10
IS5260A (is) 1999-11-19
CN1261794A (zh) 2000-08-02
CA2290974C (en) 2004-04-27
HUP0002236A3 (en) 2003-12-29
KR100366373B1 (ko) 2003-01-14
CO4940495A1 (es) 2000-07-24
JP2000514100A (ja) 2000-10-24
DZ2548A1 (fr) 2003-02-08
ID23429A (id) 2000-04-20
TNSN98124A1 (fr) 2005-03-15
HUP0002236A2 (hu) 2003-08-28
EA199900962A1 (ru) 2000-08-28
PE97199A1 (es) 1999-10-05
CA2290974A1 (en) 1999-01-14
SK181099A3 (en) 2000-07-11
NO996520D0 (no) 1999-12-28
EP0999829A1 (en) 2000-05-17
PA8454301A1 (es) 2000-09-29
AP9801280A0 (en) 1998-06-30
MA24587A1 (fr) 1998-12-31
AR015917A1 (es) 2001-05-30
AR040279A2 (es) 2005-03-23
HN1998000102A (es) 1999-01-08
KR20010013365A (ko) 2001-02-26
UA67741C2 (uk) 2004-07-15
ZA985708B (en) 2000-01-10
AU7544898A (en) 1999-01-25
UY25071A1 (es) 2000-12-29
YU68299A (sh) 2002-06-19
EA002481B1 (ru) 2002-06-27
AP1192A (en) 2003-07-23
TR199903297T2 (xx) 2000-07-21
WO1999001120A1 (en) 1999-01-14
OA11243A (en) 2003-07-24
AR040280A2 (es) 2005-03-23
HRP980377A2 (en) 1999-04-30
NO996520L (no) 2000-02-29
BR9810739A (pt) 2000-09-12
TW550087B (en) 2003-09-01
PL337804A1 (en) 2000-09-11
IL133076A0 (en) 2001-03-19

Similar Documents

Publication Publication Date Title
GC0000107A (en) Water - soluble pharmaceutical compositions in an ionic complex an the use thereof.
DE69716135D1 (en) In 6-position durch thio substituierte paclitaxele
HUP0103929A3 (en) Heterocyclyl amino methyloxazolidinones as antibacterials and pharmaceutical compositions containing the same
ZA989560B (en) Compositions containing an Ó 1,2-fucose linkage and uses thereof.
ZA979477B (en) Low residue aqueous hard surface cleaning and disinfecting compositions.
ZA969491B (en) Near tricritical point compositions containing a bleach and/or a disinfecting agent.
BG103930A (en) Eletriptan hemisulphate and caffeine containing pharmaceutical compositions
HK1024632A1 (en) Novel powder compositions
NZ239879A (en) Cleansing composition comprising two amphoteric surfactants-one being an imidazolinium derivative, the other an aminoalkanoate or iminodialkanoate, and an insoluble conditioning agent
EP0608780A3 (en) Fluorosilicon compositions as release agents.
EP1900802A3 (en) Toilet bar having a latent acidifier
BG103918A (en) Soluble sertraline compositions
HK1013627A1 (en) High solubility multicomponent inclusion complexes consisting of an acidic drug a cyclodextrin and a base
WO2001010408A3 (de) Wässrige arzneimittelformulierung von moxifloxacin oder salzen davon
AU1887399A (en) Aqueous compositions comprising complexing agents and uses therof
EP0678771A3 (en) Stable aqueous dispersions of solid particles.
WO2002062304A3 (de) Kosmetische und/oder pharmazeutische mittel acylierte aminosäure und proteinkondensat enthaltend.
IL126185A0 (en) Compositions comprising an hiv protease inhibitor such as vx 478 and a water soluble vitamin e compound such as vitamin e-tpgs
AU2619099A (en) Aqueous precious metal colloids and the use thereof
EP0665265A3 (de) Zusammensetzungen, enthaltend Metallpartikel im Nanometergrössenbereich.
BG106534A (en) Oral solution containing galanthamine and a sweetening agent
MX9708624A (es) Composiciones bacteriostaticas y su uso en fluidos de metalisteria.
CA2051892A1 (en) Hydrophobically modified carboxyalkyl hydroxyalkyl ethers of polygalactomannans
AU6202099A (en) Case-safe system
HK1028711A1 (en) Synergistic antimicrobial compositions containing dodecylmorpholine or a salt thereof and dodecylamine or a salt thereof.